• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Bromobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Bromobenzenes

Introduction to 4-bromo-1-(4-bromophenyl)methyl-1H-pyrazol-3-amine (CAS No. 956440-81-6)

4-bromo-1-(4-bromophenyl)methyl-1H-pyrazol-3-amine, with the CAS number 956440-81-6, is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrazoles, which are known for their diverse biological activities, including anti-inflammatory, analgesic, and anti-cancer properties. The presence of bromine atoms in its structure makes it particularly interesting for various applications, especially in the development of new therapeutic agents.

The molecular structure of 4-bromo-1-(4-bromophenyl)methyl-1H-pyrazol-3-amine consists of a pyrazole ring substituted with a bromomethyl group and a 4-bromophenyl group. This unique arrangement provides the compound with specific chemical and physical properties that are crucial for its biological activity. The bromine atoms contribute to the compound's lipophilicity, which can enhance its ability to cross cell membranes and interact with biological targets.

Recent studies have explored the potential of 4-bromo-1-(4-bromophenyl)methyl-1H-pyrazol-3-amine in various therapeutic areas. One notable application is in the treatment of cancer. Research has shown that this compound exhibits significant anti-proliferative effects on various cancer cell lines, including breast cancer, lung cancer, and colon cancer. The mechanism of action is believed to involve the inhibition of key signaling pathways that are dysregulated in cancer cells, such as the PI3K/AKT and MAPK pathways.

In addition to its anti-cancer properties, 4-bromo-1-(4-bromophenyl)methyl-1H-pyrazol-3-amine has also been investigated for its potential as an anti-inflammatory agent. In vitro studies have demonstrated that this compound can effectively reduce the production of pro-inflammatory cytokines, such as TNF-alpha and IL-6, in activated immune cells. This makes it a promising candidate for the treatment of inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease.

The pharmacokinetic properties of 4-bromo-1-(4-bromophenyl)methyl-1H-pyrazol-3-amine have also been studied extensively. It has been found to have good oral bioavailability and a favorable pharmacokinetic profile, which are essential for its potential use as an oral medication. Preclinical studies have shown that this compound is well-tolerated at therapeutic doses and does not exhibit significant toxicity in animal models.

Clinical trials are currently underway to further evaluate the safety and efficacy of 4-bromo-1-(4-bromophenyl)methyl-1H-pyrazol-3-amine. Early results from phase I trials have been promising, with the compound showing good tolerability and preliminary evidence of clinical activity in patients with advanced solid tumors. These findings have paved the way for more advanced clinical trials to assess its potential as a novel therapeutic agent.

In conclusion, 4-bromo-1-(4-bromophenyl)methyl-1H-pyrazol-3-amine (CAS No. 956440-81-6) is a promising compound with a wide range of potential applications in medicine. Its unique chemical structure and biological activities make it an attractive candidate for further research and development. As ongoing studies continue to uncover its full potential, this compound may play a significant role in advancing treatments for various diseases, particularly cancer and inflammatory conditions.

• 1052569-75-1(1-(3-bromobenzyl)-1h-pyrazol-5-amine)
• 400753-16-4(4-Bromo-1-(4-chlorobenzyl)-1H-pyrazol-3-amine)
• 895929-98-3(4-bromo-1-(3,4-dichlorobenzyl)-1H-pyrazol-3-amine)
• 1177315-04-6(1-(2-bromophenyl)methyl-1H-pyrazol-3-amine)
• 1171985-74-2(1-Benzyl-4-bromo-1H-pyrazol-3-amine)
• 925580-09-2(1-(4-Bromophenyl)methylpyrazol-3-amine)
• 1001757-57-8(4-bromo-1-(4-fluorophenyl)methyl-1H-pyrazol-3-amine)
• 1001757-56-7(4-Bromo-1-(2-fluorobenzyl)-1H-pyrazol-3-amine)
• 895929-86-9(4-bromo-1-(4-methylbenzyl)-1H-pyrazol-3-amine)
• 956986-52-0(1-(4-Bromophenyl)methyl-1H-pyrazol-5-amine)